Background: Schizophrenia is a heterogeneous neuropsychiatric disorder, categorized by positive, negative, and cognitive symptoms. In trying to improve the diagnosis and treatment of schizophrenia, researchers have turned to “dual hit” models of schizophrenia that are able to reproduce all symptoms of the disorder. The main objective of this protocol is to present a transparent process on how we plan to review the existing international literature on the effectiveness of “dual hit” models used to induce schizophrenia on rodents. Methods: Literature search strategies will be developed using medical search headings (MeSH). The MEDLINE (PubMed), EMBASE, and Google Scholar databases will be used to search for electronically published studies. W...
The strategies used in preclinical research in schizophrenia have evolved from experiments focused o...
Copyright © 2012 Manavi Chatterjee et al. This is an open access article distributed under the Creat...
Schizophrenia is a severe psychiatric disorder with about 1% prevalance. NMDA receptor antagonists s...
Valid mouse models of schizophrenia (SCZ) are valuable preclinical research tools to investigate pat...
Schizophrenia is a debilitating disorder comprising positive, negative and cognitive deficits with a...
OBJECTIVE: To assess whether systematic reviews (SRs), the gold standard for scientific research, ca...
3. Genetic model of schizophrenia based on inhibition of NMDA receptor.................................
<p>INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...
Number of patients suffering from schizophrenia is increasing daily, subsequently, increasing the ne...
Schizophrenia is a chronic, common and debilitating illness which causes serious psychosocial impair...
For many years, animal models are of great importance for biological and pharmacological research. T...
abstract: Animal models have led to important discoveries in biomedical research; their utility to p...
Data collected as part of Doctorate thesis submitted for examination at the University of Edinburgh ...
The strategies used in preclinical research in schizophrenia have evolved from experiments focused o...
International audienceSchizophrenia is a frequent psychiatric disease (prevalence 1%). Unfortunately...
The strategies used in preclinical research in schizophrenia have evolved from experiments focused o...
Copyright © 2012 Manavi Chatterjee et al. This is an open access article distributed under the Creat...
Schizophrenia is a severe psychiatric disorder with about 1% prevalance. NMDA receptor antagonists s...
Valid mouse models of schizophrenia (SCZ) are valuable preclinical research tools to investigate pat...
Schizophrenia is a debilitating disorder comprising positive, negative and cognitive deficits with a...
OBJECTIVE: To assess whether systematic reviews (SRs), the gold standard for scientific research, ca...
3. Genetic model of schizophrenia based on inhibition of NMDA receptor.................................
<p>INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...
Number of patients suffering from schizophrenia is increasing daily, subsequently, increasing the ne...
Schizophrenia is a chronic, common and debilitating illness which causes serious psychosocial impair...
For many years, animal models are of great importance for biological and pharmacological research. T...
abstract: Animal models have led to important discoveries in biomedical research; their utility to p...
Data collected as part of Doctorate thesis submitted for examination at the University of Edinburgh ...
The strategies used in preclinical research in schizophrenia have evolved from experiments focused o...
International audienceSchizophrenia is a frequent psychiatric disease (prevalence 1%). Unfortunately...
The strategies used in preclinical research in schizophrenia have evolved from experiments focused o...
Copyright © 2012 Manavi Chatterjee et al. This is an open access article distributed under the Creat...
Schizophrenia is a severe psychiatric disorder with about 1% prevalance. NMDA receptor antagonists s...